Web Analytics
OBIO (NASDAQ) 株価分析 | ORCHESTRA BIOMED HOLDINGS INC. – Deepscope
MARKET

Select Market Data Region

OBIO 株価分析 — Orchestra Biomed Holdings Inc. (Healthcare >> Biotechnology)

OBIO に関するよくある質問

OBIOのPER(株価収益率)は?

Orchestra Biomed Holdings Inc.(OBIO)は現在PER 39.50倍で取引されています。

OBIOのROE(自己資本利益率)は?

Orchestra Biomed Holdings Inc.のROEは-107.20%です。

OBIOの配当利回りは?

Orchestra Biomed Holdings Inc.の配当利回りは0.00%です。

OBIOの品質スコア(Quality Score)は?

当社のAIはOBIOの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

OBIOは今が買い時ですか?

当社AIのタイミングスコアは100点中64点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

OBIOはどのセクターに属しますか?

Orchestra Biomed Holdings Inc.はHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-08-04 | FS: 2026-03-31)

OBIO AI Analysis Summary

Our AI summary for OBIO: Orchestra Biomed Holdings Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 39.50, ROE of -107.20%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 64/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

OBIO

Orchestra Biomed Holdings Inc.
USD 4.27
0.15 (3.64%) Day Change
39.50
P/E
0.30
D/E
-107.2%
ROE
-54.3%
ROA
0.00%
Div Yield
16.95
PEG

ORCHESTRA BIOMED HOLDINGS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare   Watchlist   Myport
USD 4.27
Price
0.15 (3.64%)
Day Change
NEWS SCORE: 99

OBIO, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析 45%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 4.27
  PBV / Sector
4.84 / 44,022.72
  Earning Per Share -0.95
  PE / Sector
39.50 / 19.17
  PEG or PE/Growth / Sector
16.95 / 1.24
  Average 1M Daily Value
0.75 M
GREAT
  Average 1W Daily Value
0.71 M
GREAT
Timing Factors 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 64%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-166.96 / 98.24
  NPM Average (%) / Sector
-1,073.72 / -1,697.63
  NPM Change Average (%) / Sector
7.49 / 5,097.97
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-54.28 / 185,260.96
  ROA Average (%) / Sector
-53.41 / 36,684.70
  ROA Change Average (%) / Sector
19.39 / 422,221.66
GOOD
  ROE (%) / Sector
-107.20 / 243,762.23
  ROE Average (%) / Sector
-102.34 / 48,758.47
  ROE Change Average (%) / Sector
35.79 / 424,968.10
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.04
  Dividend Average (%) / Sector
N/A / 17.04
  Dividend Change Average (%) / Sector
N/A / -0.49
登録情報
X
  Analyze Date 2026-08-05 08:00:37
  Symbol OBIO
  Name ORCHESTRA BIOMED HOLDINGS INC.
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 59.88 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 246.71 / 9,586.08
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 150 Union Square Drive, New Hope, PA, United States, 18938

Phone: 215 862 5797

Website: https://www.orchestrabiomed.com

Employees: 86

Sector: Healthcare >> Biotechnology

Description: Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral vascular disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
4
4
4
Buy
3
3
3
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
Consensus
Strong Buy 4.57
Strong Buy 4.57
Strong Buy 4.57
Target Price
USD 12.43
USD 12.17
USD 12.17

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Biotechnology

OBIO (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Biotechnology

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
OBIO
OBIO
USD 4.27 (3.64%)
+ Watch + Port Chart